Innophos Holdings (IPHS) Releases Earnings Results, Beats Expectations By $0.06 EPS

Innophos Holdings (IPHS) reported quarterly earnings results on Monday, Aug-1-2016. The company said it had a profit of $0.63 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.06. Analysts had a consensus of $0.57. The company posted revenue of $181.90 million in the period, compared to analysts expectations of $199.70 million. The company’s revenue was down -16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.65 EPS.

Innophos Holdings closed down -0.52 points or -1.19% at $43.06 with 1,98,761 shares getting traded on Friday. Post opening the session at $43.46, the shares hit an intraday low of $42.82 and an intraday high of $43.58 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

In a different news, on Jun 24, 2016, Joseph Golowski (VP-Specialty Ingredients) sold 5,000 shares at $40.46 per share price. According to the SEC, on May 24, 2016, Robert J Zatta (director) purchased 1,000 shares at $37.11 per share price. On Feb 25, 2016, John M Steitz (director) purchased 10,000 shares at $26.95 per share price, according to the Form-4 filing with the securities and exchange commission.

Innophos Holdings Inc. is a producer of performance-critical and nutritional specialty ingredients with applications in food beverage dietary supplements pharmaceutical oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Bioactive mineral ingredients are mineral based ingredients for food beverage and dietary supplement end markets that are manufactured to be readily digestible. The Company has four product lines: Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA); Technical Grade Sodium Tripolyphosphate (STPP) and Detergent Grade PPA and Granular Triple Super Phosphate (GTSP) and other. The Company also produces a range of botanical enzyme and mineral-based ingredients through a variety of production processes customized through spray drying roller compactions grinding wet granulations solvent extractions and custom blending resulting in over 2000 product formulations.

Innophos Holdings

Leave a Reply

Innophos Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Innophos Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.